Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Powell

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Annual Review of Immunology|December 6, 2011
Regulation of immune responses by mTORJonathan D Powell, Kristen N Pollizzi, Emily B Heikamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2009
Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiationChristopher J Gamper, Agoston T Agoston, William G Nelson, et al.
Cold Spring Harbor Symposia on Quantitative Biology|October 9, 2013
A modified model of T-cell differentiation based on mTOR activity and metabolismJonathan D Powell, Emily B Heikamp, Kristen N Pollizzi, et al.
Plos One|January 30, 2014
Egr3 induces a Th17 response by promoting the development of γδ T cellsRose M Parkinson, Samuel L Collins, Maureen R Horton, et al.
Nature Reviews. Drug Discovery|August 1, 2019
Targeting metabolism to regulate immune responses in autoimmunity and cancerChirag H Patel, Robert D Leone, Maureen R Horton, et al.
International Journal of Molecular Sciences|June 10, 2020
Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical PerspectiveHuang-Yu Yang, Chao-Yi Wu, Jonathan D Powell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
Anergic T cells are metabolically anergicYan Zheng, Greg M Delgoffe, Christian F Meyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcriptionSamuel Collins, Lawrence A Wolfraim, Charles G Drake, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance inductionAmy Allen, Yan Zheng, Lawrence Gardner, et al.
Cancer Immunology, Immunotherapy : CII|November 26, 2011
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptorAdam T Waickman, Angela Alme, Liana Senaldi, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Annual Review of Immunology|December 6, 2011
Regulation of immune responses by mTORJonathan D Powell, Kristen N Pollizzi, Emily B Heikamp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2009
Identification of DNA methyltransferase 3a as a T cell receptor-induced regulator of Th1 and Th2 differentiationChristopher J Gamper, Agoston T Agoston, William G Nelson, et al.
Cold Spring Harbor Symposia on Quantitative Biology|October 9, 2013
A modified model of T-cell differentiation based on mTOR activity and metabolismJonathan D Powell, Emily B Heikamp, Kristen N Pollizzi, et al.
Plos One|January 30, 2014
Egr3 induces a Th17 response by promoting the development of γδ T cellsRose M Parkinson, Samuel L Collins, Maureen R Horton, et al.
Nature Reviews. Drug Discovery|August 1, 2019
Targeting metabolism to regulate immune responses in autoimmunity and cancerChirag H Patel, Robert D Leone, Maureen R Horton, et al.
International Journal of Molecular Sciences|June 10, 2020
Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical PerspectiveHuang-Yu Yang, Chao-Yi Wu, Jonathan D Powell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2009
Anergic T cells are metabolically anergicYan Zheng, Greg M Delgoffe, Christian F Meyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcriptionSamuel Collins, Lawrence A Wolfraim, Charles G Drake, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 7, 2004
The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance inductionAmy Allen, Yan Zheng, Lawrence Gardner, et al.
Cancer Immunology, Immunotherapy : CII|November 26, 2011
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptorAdam T Waickman, Angela Alme, Liana Senaldi, et al.
Pageof 14